We are live on
!
Find out more
Plus Therapeutics
PSTV
PSTV
8 hedge funds and large institutions have $609K invested in Plus Therapeutics in 2018 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
33% more funds holding
Funds holding: 6 → 8 (+2)
0% more ownership
Funds ownership: 0% → 0% (+0%)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
52% less capital invested
Capital invested by funds: $1.28M → $609K (-$667K)
Holders
8
Holders Change
+2
Holders Change %
+33.33%
% of All Funds
0.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
2
Closed
1
Calls
$67K
Puts
–
Net Calls
+$67K
Net Calls Change
+$54K
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$190K |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
+$95.2K |
| 3 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$95.2K |
| 4 |
Renaissance Technologies
New York
|
+$47.6K |
Top Sellers
| 1 |
JG
Jefferies Group
New York
|
-$214K |
| 2 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$143K |
| 3 |
BlackRock
New York
|
-$47.6K |
| 4 |
Creative Planning
Overland Park,
Kansas
|
-$22K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$16K |
